Form 8-K - Current report:
SEC Accession No. 0000950170-24-123727
Filing Date
2024-11-08
Accepted
2024-11-08 09:07:40
Documents
12
Period of Report
2024-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sana-20241108.htm   iXBRL 8-K 47726
2 EX-99.1 sana-ex99_1.htm EX-99.1 301240
  Complete submission text file 0000950170-24-123727.txt   493917

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sana-20241108.xsd EX-101.SCH 31887
14 EXTRACTED XBRL INSTANCE DOCUMENT sana-20241108_htm.xml XML 4890
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 241438190
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)